Inhibition of MYCN by a PNA anti-gene in alveolar rhabdomyosarcoma
收藏官方服务：
资源简介：
Inhibition of MYCN by a PNA anti-gene in alveolar rhabdomyosarcoma
应用场景：
创建时间：
2011-12-31
相关数据集
Data_Sheet_1_Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors.pdf
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma with poor prognosis. RMS frequently show Hedgehog (HH) pathway activity, which is predominantly seen in the embryonal subtype (E
NIAID Data Ecosystem90
Affymetrix SNP array data for pediatric rhabdomyosarcoma (RMS). Homo sapiens
To elucidate the pathogenesis of rhabdomyosarcoma (RMS), particularly for different subgroups, we performed a SNP array-based copy number analysis of 54 RMS specimens from primary cases with ERMS (N =
NIAID Data Ecosystem60
Rhabdomyosarcoma, NOS - Male, 3 - Tissue image [5280730021706121]
This is the histopathological image of BLADDER tissue sample obtained in Medical University Gdańsk and deposited in ZMDL-GUMED. The sample image was taken using: Pannoramic 250 3DHistech slide scanner
DataCite Commons2022-05-28 更新50
Enhancer invasion shapes MYCN dependent transcriptional amplification in neuroblastoma [ATAC-seq]
In neuroblastoma, amplification of the oncogenic basic helix-loop-helix (bHLH) transcription factor (TF) MYCN is the defining prognosticator of high-risk disease, occurs in one-third of neuroblastoma,
NIAID Data Ecosystem70
Enhancer invasion shapes MYCN dependent transcriptional amplification in neuroblastoma [ATAC-seq]. Homo sapiens
In neuroblastoma, amplification of the oncogenic basic helix-loop-helix (bHLH) transcription factor (TF) MYCN is the defining prognosticator of high-risk disease, occurs in one-third of neuroblastoma,
NIAID Data Ecosystem60
